How We’ve Been Cashing In On The GLP-1 Craze
The booming market for weight-loss drugs, particularly GLP-1 agonists, have led to substantial gains in drugmakers Novo Nordisk (NVO) and Eli Lilly (LLY). The latter is seeing its share price approach the $1,000 level, putting it out of reach for most investors.
But we’ve been able to generate thousands of dollars from LLY over the past year and boost our rates of return using a simple options-selling strategy.
Simple Strategy Yields 98% Win Rate in H1
We’ve closed 50 winning trades and just one loser in Options Income Weekly so far in 2024, generating consistent income despite the low-volatility environment.
Let’s take a closer look at our results and how we’ve been navigating the market this year.
Investors Are No Longer Fearful, But Should They Be?
Underwhelming earning reports and other economic data are showing that the Fed could get the data it needs to finally consider cutting rates sooner than later. However, as my colleagues have said many times, eventually bad news is going to be just that – bad news. For now, investors seem hopeful that a weakening economy will lead to cut rates that will, in turn, boost the economy back higher while keeping inflation at bay. So, how bad is the data coming in and what can you do about it to keep your portfolio safe?
Quarter-End Reflections: Seasonal Patterns and Market Predictions
It may be hard to believe, but we’re nearing the end of another quarter in 2024, which means volatility should pick up with the return of earnings season. We’re also nearing a presidential election in the U.S., but first, let’s not forget inflation and the Fed. Before we get too far ahead of ourselves, let’s take a look at a few of the items impacting the market now, and see if we can tell where the market may be heading.
It’s Nvidia’s Market. We’re Just Trading In It.
As goes Nvidia, so goes the market these days it seems, with the stock dragging down the S&P 500 late last week.
But 5K Challenge members were able to capitalize on the runup in shares before the stock’s recent pullback with two back-to-back one-day trades.
Don’t Let the Quadruple Witching Scare You
Four times a year, once each quarter, we are met with what is called a quadruple witching day, and no it has nothing to do with ghouls or goblins. Yet some investors stay away from the market even though there are plenty of opportunities if you know what to look for. Let’s discuss what the day is, what typically happens before and after the day occurs, and how you can profit from it.
We Just Earned $1K+ Profits on 2 Tech Faves
Income Masters members have booked three winners in a row on Microsoft (MSFT), pocketing more than $1,500 in cash in less than a month.
Meanwhile, 5K Challenge members have used the same strategy on AI darling Nvidia (NVDA) and earned $1,053 in profits in less than a week.
Find out how they are doing it here.
Member Request Fuels Options Win
A member request led us to investigate a biotech company as a potential income opportunity. Not only did we like what we uncovered, but a larger-than-expected market move led to a profitable exit on the trade in less than 24 hours.
Find out which company we traded here.
Market Ignores Hawkish Fed, Cheers CPI
The Fed rate frenzy is almost getting as hyped as seeing Roaring Kitty return to trading GME after years of being silent. All investors watched as the Consumer Price Index (CPI) numbers signaled ongoing disinflation. While stocks shot higher on Wednesday, investors ignored the Fed presentation later in the day. That was a mistake as the Fed laid out a troubling scenario.
Let’s start with the good news. Consumer Prices are rising less than the consensus range. For example, the year-over-year number was expected to increase by 3.4%, whereas the actual CPI number came in at 3.3%.
45 DTE: The Sweet Spot for Options?
For short-term option traders, 45 days to expiration might sound like a lifetime. But research shows some benefits associated with this time frame.
Find out how we’ve been utilizing longer-dated options in the pursuit of short-term profits.
